BB BIOTECH AG

Q2 2014 13F Holdings Report, Stock Holdings

Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen, Switzerland
Holdings as of
June 30, 2014
Value $
$2.1B
Num holdings
24
Date filed
8/7/2014, 03:43 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2014 - May 8, 2014
Next filing
Q3 2014 - Nov 13, 2014
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2014 Q2 compared to 2014 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ivo Betschart SIGNING AUTHORITY Schaffhausen, Switzerland 8/6/2014

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $6.17B Kuesnacht, Switzerland 028-17462

Other Included Managers (3):

Num Name Location File Number
1 Biotech Focus N.V. 028-11193
2 Biotech Invest N.V. 028-11191
3 Biotech Target N.V. 028-11189